Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Non-Current Debt (2016 - 2026)

Scienture Holdings' (SCNX) quarterly Non-Current Debt came in at $9.6 million in Q2 2026, up 378.43% year-over-year from $2.0 million in Q2 2025, and up 20862.59% quarter-over-quarter from $45646.0 in Q4 2025.

Analysis

Scienture Holdings (SCNX) Non-Current Debt (2016 - 2026) Analysis & Trends

Scienture Holdings has disclosed Non-Current Debt across 10 years of filings, most recently posting $9.6 million for Q2 2026.

  • In Q2 2026, Non-Current Debt rose 378.43% year-over-year to $9.6 million; the TTM figure through Jun 2026 stood at $9.6 million (up 378.43% YoY), while the FY2025 annual figure was $45646.0, down 97.72% from the prior year.
  • Non-Current Debt came in at $9.6 million for Q2 2026 at Scienture Holdings, up from $45646.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $9.6 million in Q2 2026 to a low of $45646.0 in Q4 2025.
  • Average Non-Current Debt over 5 years is $2.5 million, with a median of $2.0 million recorded in 2024.
  • Year-over-year, Non-Current Debt surged 1866.5% in 2023 and sank 97.72% in 2025.
  • Over 5 years, Non-Current Debt stood at $333333.0 in 2022, then surged by 1866.5% to $6.6 million in 2023, then slumped by 69.49% to $2.0 million in 2024, then slumped by 97.72% to $45646.0 in 2025, then jumped by 20862.59% to $9.6 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $9.6 million in Q2 2026, $45646.0 in Q4 2025, and $2.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 12.09 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 11.61 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 150.67 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 2.57 Bn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 20.74 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 280.16 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 1.26 Bn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 609.56 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00 9.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.57 Mn
Dec 31, 2025 45,646.00
Sep 30, 2025 2.00 Mn
Jun 30, 2025 2.00 Mn
Mar 31, 2025 2.00 Mn
Dec 31, 2024 2.00 Mn
Sep 30, 2024 2.00 Mn
Dec 31, 2023 6.56 Mn
Sep 30, 2023 5.26 Mn
Dec 31, 2022 333,333.00
Sep 30, 2022 333,333.00
Jun 30, 2022 333,333.00
Mar 31, 2022 333,333.00
Sep 30, 2020 225,000.00
Jun 30, 2020 225,000.00
Mar 31, 2020 225,000.00
Dec 31, 2019 225,000.00
Sep 30, 2019 300,000.00
Jun 30, 2019 522,552.00
Mar 31, 2019 522,552.00